Supplemental material
Drug Delivery
Volume 24, 2017 - Issue 1
Related Research Data
Mixed Micelles of Doxorubicin Overcome Multidrug Resistance by Inhibiting the Expression of P-Glycoprotein.
Source:
American Scientific Publishers
Stimuli-responsive nanocarriers for drug delivery
Source:
Springer Science and Business Media LLC
D-α-tocopheryl polyethylene glycol 1000 succinate functionalized nanographene oxide for cancer therapy.
Source:
Future Medicine
Doxorubicin conjugated to d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS): Conjugation chemistry, characterization, in vitro and in vivo evaluation
Source:
Elsevier BV
Docetaxel (DTX)-loaded polydopamine-modified TPGS-PLA nanoparticles as a targeted drug delivery system for the treatment of liver cancer.
Source:
Elsevier BV
Targeting vitamin E TPGS–cantharidin conjugate nanoparticles for colorectal cancer therapy
Source:
Royal Society of Chemistry (RSC)
Reversal of multidrug resistance by co-delivery of paclitaxel and lonidamine using a TPGS and hyaluronic acid dual-functionalized liposome for cancer treatment.
Source:
Elsevier BV
Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications.
Source:
Elsevier BV
Vitamin E-based nanomedicines for anti-cancer drug delivery
Source:
Elsevier BV
Enhanced tumor therapy via drug co-delivery and in situ vascular-promoting strategy.
Source:
Elsevier BV
A safe, simple and efficient doxorubicin prodrug hybrid micelle for overcoming tumor multidrug resistance and targeting delivery.
Source:
Elsevier BV
The Effect of Surfactant on Paclitaxel Nanocrystals: An In Vitro and In Vivo Study.
Source:
American Scientific Publishers
Inhibition of P-Glycoprotein by D-α-Tocopheryl Polyethylene Glycol 1000 Succinate (TPGS)
Source:
Springer Science and Business Media LLC
Advances in P-glycoprotein-based approaches for delivering anticancer drugs: pharmacokinetic perspective and clinical relevance.
Source:
(:unav)
Synergistic inhibition of breast cancer metastasis by silibinin-loaded lipid nanoparticles containing TPGS.
Source:
Elsevier BV
Enhancement of curcumin solubility…
Source:
Wiley
pH-sensitive docetaxel-loaded D-α-tocopheryl polyethylene glycol succinate-poly(β-amino ester) copolymer nanoparticles for overcoming multidrug resistance.
Source:
American Chemical Society (ACS)
Current trends in the use of vitamin E-based micellar nanocarriers for anticancer drug delivery
Source:
Informa UK Limited
A unique squalenoylated and nonpegylated doxorubicin nanomedicine with systemic long-circulating properties and anticancer activity
Source:
Proceedings of the National Academy of Sciences
ROS-triggered and regenerating anticancer nanosystem: an effective strategy to subdue tumor's multidrug resistance.
Source:
Elsevier BV
pH-, redox dual-sensitive poly(β-amino ester)-g-TPGS copolymer nanoparticles for drug delivery and inhibition of multidrug resistance in cancer
Source:
Elsevier BV
Paclitaxel-loaded PCL-TPGS nanoparticles: in vitro and in vivo performance compared with Abraxane®.
Source:
Elsevier BV
Vitamin E analogues as a novel group of mitocans: anti-cancer agents that act by targeting mitochondria.
Source:
Elsevier BV
Micelles of d-α-Tocopheryl Polyethylene Glycol 2000 Succinate (TPGS 2K) for Doxorubicin Delivery with Reversal of Multidrug Resistance.
Source:
American Chemical Society (ACS)
Nucleolin targeting AS1411 aptamer modified pH-sensitive micelles for enhanced delivery and antitumor efficacy of paclitaxel
Source:
Springer Science and Business Media LLC
Multi-drug loaded vitamin E-TPGS nanoparticles for synergistic drug delivery to overcome drug resistance in tumor treatment
Source:
Elsevier BV
PEG-Derivatized Dual-Functional Nanomicelles for Improved Cancer Therapy.
Source:
Frontiers Media S.A.
TPGS-stabilized NaYbF4:Er upconversion nanoparticles for dual-modal fluorescent/CT imaging and anticancer drug delivery to overcome multi-drug resistance.
Source:
Elsevier BV
The applications of Vitamin E TPGS in drug delivery.
Source:
Elsevier BV
Application of d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) in transdermal and topical drug delivery systems (TDDS)
Source:
Springer Science and Business Media LLC
Cancer nanomedicine: progress, challenges and opportunities.
Source:
Springer Science and Business Media LLC
Development of docetaxel-loaded vitamin E TPGS micelles: formulation optimization, effects on brain cancer cells and biodistribution in rats
Source:
Future Medicine Ltd
Suppression of Tumor Growth In vivo by the Mitocan α-tocopheryl Succinate Requires Respiratory Complex II
Source:
American Association for Cancer Research (AACR)
Hydrogen-bonded and reduction-responsive micelles loading atorvastatin for therapy of breast cancer metastasis.
Source:
Elsevier BV
Codelivery of sorafenib and curcumin by directed self-assembled nanoparticles enhances therapeutic effect on hepatocellular carcinoma.
Source:
American Chemical Society (ACS)
TPGS modified reduced bovine serum albumin nanoparticles as a lipophilic anticancer drug carrier for overcoming multidrug resistance
Source:
Royal Society of Chemistry (RSC)
Vitamin E reverses multidrug resistance in vitro and in vivo.
Source:
Elsevier BV
Biodegradable mixed MPEG-SS-2SA/TPGS micelles for triggered intracellular release of paclitaxel and reversing multidrug resistance.
Source:
Dove Medical Press
The anticancer efficacy of paclitaxel liposomes modified with mitochondrial targeting conjugate in resistant lung cancer.
Source:
Elsevier BV
Transferrin receptor targeted PLA-TPGS micelles improved efficacy and safety in docetaxel delivery
Source:
Elsevier BV
Redox-triggered mitoxantrone prodrug micelles for overcoming multidrug-resistant breast cancer.
Source:
Taylor & Francis
Dual-functionalized liposome by co-delivery of paclitaxel with sorafenib for synergistic antitumor efficacy and reversion of multidrug resistance.
Source:
Taylor & Francis
Nitric oxide releasing d-α-tocopheryl polyethylene glycol succinate for enhancing antitumor activity of doxorubicin.
Source:
American Chemical Society (ACS)
d-α-Tocopherol Polyethylene Glycol Succinate-Based Redox-Sensitive Paclitaxel Prodrug for Overcoming Multidrug Resistance in Cancer Cells
Source:
American Chemical Society (ACS)
Novel in situ gel systems based on P123/TPGS mixed micelles and gellan gum for ophthalmic delivery of curcumin
Source:
Elsevier BV
Vitamin E-based micelles enhance the anticancer activity of doxorubicin.
Source:
Elsevier BV
Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system.
Source:
Future Medicine Ltd
The cancer targeting potential of D-α-tocopheryl polyethylene glycol 1000 succinate tethered multi walled carbon nanotubes.
Source:
Elsevier BV
Simultaneous inhibition of tumor growth and angiogenesis for resistant hepatocellular carcinoma by co-delivery of sorafenib and survivin small hairpin RNA.
Source:
American Chemical Society (ACS)
mPEG-b-PCL/TPGS mixed micelles for delivery of resveratrol in overcoming resistant breast cancer
Source:
Informa Healthcare
Dendrimer-TPGS mixed micelles for enhanced solubility and cellular toxicity of taxanes.
Source:
Elsevier BV
Cetuximab conjugated vitamin E TPGS micelles for targeted delivery of docetaxel for treatment of triple negative breast cancers.
Source:
Elsevier BV
In Situ Lipidization as a New Approach for the Design of a Self Microemulsifying Drug Delivery System (SMEDDS) of Doxorubicin Hydrochloride for Oral Administration.
Source:
American Scientific Publishers
Dual-functionalized liposome by co-delivery of paclitaxel with sorafenib for synergistic antitumor efficacy and reversion of multidrug resistance.
Source:
Taylor & Francis
Vitamin E: a dark horse at the crossroad of cancer management
Source:
Elsevier BV
Dual-functionalized liposome by co-delivery of paclitaxel with sorafenib for synergistic antitumor efficacy and reversion of multidrug resistance.
Source:
Taylor & Francis
Vitamin E analogs, a novel group of "mitocans," as anticancer agents: the importance of being redox-silent.
Source:
American Society for Pharmacology & Experimental Therapeutics (ASPET)
Linking provided by
